dc.contributor.author |
Novitskaya, ES |
en |
dc.contributor.author |
Dean, SJ |
en |
dc.contributor.author |
Craig, Jennifer |
en |
dc.contributor.author |
Alexandroff, AB |
en |
dc.date.accessioned |
2017-08-08T21:50:27Z |
en |
dc.date.issued |
2011-05 |
en |
dc.identifier.citation |
Clinics in Dermatology, 29(3):295-299 May 2011 |
en |
dc.identifier.issn |
0738-081X |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/34916 |
en |
dc.description.abstract |
Identifying contact allergens in ophthalmic medications can be a challenging and daunting experience. We summarize data on topical ophthalmic medications with the potential to cause periorbital contact dermatitis and allergic conjunctivitis, highlighting current dilemmas and controversies in this area. The following groups of allergens are reviewed: preservatives, antiglaucoma medications (prostaglandin analogues, β-blockers, carbonic anhydrase inhibitors, parasympathomimetics, sympathomimetics), antiinflammatory medications (nonsteroidal antiinflammatory drugs, corticosteroids), antibiotics, antivirals, antiallergic medications (antihistamines, cromones), anaesthetics, mydriatics, and cycloplegics. |
en |
dc.description.uri |
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290062800007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=6e41486220adb198d0efde5a3b153e7d |
en |
dc.language |
English |
en |
dc.publisher |
Elsevier |
en |
dc.relation.ispartofseries |
Clinics in Dermatology |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://sherpa.ac.uk/romeo/issn/0738-081X/
https://www.elsevier.com/about/our-business/policies/sharing |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Science & Technology |
en |
dc.subject |
Life Sciences & Biomedicine |
en |
dc.subject |
Dermatology |
en |
dc.subject |
DERMATOLOGY |
en |
dc.subject |
PERIORBITAL DERMATITIS |
en |
dc.subject |
BRIMONIDINE |
en |
dc.subject |
HYPERSENSITIVITY |
en |
dc.subject |
APRACLONIDINE |
en |
dc.subject |
PRESERVATIVES |
en |
dc.subject |
0.5-PERCENT |
en |
dc.subject |
PRODUCTS |
en |
dc.subject |
GLAUCOMA |
en |
dc.title |
Current dilemmas and controversies in allergic contact dermatitis to ophthalmic medications |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1016/j.clindermatol.2010.11.008 |
en |
pubs.issue |
3 |
en |
pubs.begin-page |
295 |
en |
pubs.volume |
29 |
en |
dc.rights.holder |
Copyright: Elsevier |
en |
dc.identifier.pmid |
21496737 |
en |
pubs.author-url |
http://www.sciencedirect.com/science/article/pii/S0738081X10002166 |
en |
pubs.end-page |
299 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
210402 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Ophthalmology Department |
en |
dc.identifier.eissn |
1879-1131 |
en |
pubs.record-created-at-source-date |
2017-08-09 |
en |
pubs.online-publication-date |
2011-04-13 |
en |
pubs.dimensions-id |
21496737 |
en |